Ozempic cuts risk of severe COVID in people with obesity ...Middle East

(NewsNation) — The popular weight loss drugs Ozempic and Wegovy may reduce the rates of severe COVID-19 reactions, including death, a new study found. Published in the Journal of the American College of Cardiology, the trial examined 17,604 people over more than three years. It found that, while taking semaglutide once a weekly did not reduce rates of COVID-19 overall, it led to fewer "COVID-19 related adverse events." Placebo-takers recorded a 3.1% occurrence, while those on the weight loss drugs noted 2.6%. Compounded weight loss drugs: What are people saying about them? Participants were: 45 years or older Overweight or had obesity Diagnosed with card

Hence then, the article about ozempic cuts risk of severe covid in people with obesity was published today ( Tuesday 03/09/2024 - 02:49 PM ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ozempic cuts risk of severe COVID in people with obesity )

Also on site :

• Netflix, Bengali Streamer Hoichoi Partner to Bring Series to Hindi, Tamil and Telugu Audiences
• ‘Nobody Wants This’ Season 3 Review: Kristen Bell and Adam Brody’s Netflix Romance Levels Up but Can’t Ditch Old Habits
• Le Creuset’s ‘Beautiful and Versatile’ Cocotte Baking Dish Makes a ‘Great Gift’ and Is Just $22 Ahead of the Holidays